News Detail

This United Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Benzinga · 04/25 12:26

Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Canaccord Genuity analyst Joseph Vafi downgraded the rating for ASGN Incorporated (NYSE:ASGN) from Buy to Hold and lowered the price target from $115 to $55. ASGN shares closed at $51.76 on Thursday. See how other analysts view this stock.
JP Morgan analyst Alexei Gogolev downgraded SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) from Overweight to Neutral and lowered the price target from $90 to $86. SS&C Technologies shares closed at $77.43 on Thursday. See how other analysts view this stock.
Macquarie analyst Linda Huang downgraded the rating for TAL Education Group (NYSE:TAL) from Outperform to Neutral and cut the price target from $14.5 to $10.9. TAL Education shares closed at $8.93 on Thursday. See how other analysts view this stock.
Wells Fargo analyst Tiago Fauth downgraded United Therapeutics Corporation (NASDAQ:UTHR) from Overweight to Equal-Weight and slashed the price target from $395 to $314. United Therapeutics shares closed at $296.42 on Thursday. See how other analysts view this stock.

Considering buying UTHR stock? Here’s what analysts think:

Read This Next:

Alphabet, Intel And 3 Stocks To Watch Heading Into Friday

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.